ANAVEX3-71

· Anavex Life Sciences Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANAVEX3-71, covering 2025-05-04 to 2025-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ANAVEX3-71 in Adults With Schizophrenia [Phase 2]